[HTML][HTML] A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome
JH Lee, JH Jang, J Park, S Park, YD Joo, YK Kim… - …, 2011 - ncbi.nlm.nih.gov
JH Lee, JH Jang, J Park, S Park, YD Joo, YK Kim, HG Kim, CW Choi, SH Kim, SK Park…
Haematologica, 2011•ncbi.nlm.nih.govA prospective multicenter observational study of decitabine treatment in Korean patients with
myelodysplastic syndrome - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List Haematologica v.96(10);
2011 Oct PMC3186304 Other Formats PDF (394K) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
myelodysplastic syndrome - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List Haematologica v.96(10);
2011 Oct PMC3186304 Other Formats PDF (394K) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
Abstract
Background
Decitabine was evaluated for its efficacy and safety in Korean patients with myelodysplastic syndrome with IPSS score of 0.5 or over.
ncbi.nlm.nih.gov